These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 32753127)
21. Intravenous bevacizumab for complications of hereditary hemorrhagic telangiectasia: a review of the literature. Arizmendez NP; Rudmik L; Poetker DM Int Forum Allergy Rhinol; 2015 Nov; 5(11):1042-7. PubMed ID: 26202958 [TBL] [Abstract][Full Text] [Related]
22. Low dose of bevacizumab is safe and effective in preventing bleeding episodes in hereditary hemorrhagic telangiectasia. Lazaraki G; Akriviadis E; Pilpilidis I; Parisi I; Tzilves D; Tarpangos A Am J Gastroenterol; 2011 Dec; 106(12):2204-6. PubMed ID: 22138950 [No Abstract] [Full Text] [Related]
23. Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia. Al-Samkari H; Kritharis A; Rodriguez-Lopez JM; Kuter DJ J Intern Med; 2019 Feb; 285(2):223-231. PubMed ID: 30191646 [TBL] [Abstract][Full Text] [Related]
24. Systemic Bevacizumab for Hereditary Hemorrhagic Telangiectasia: Considerations from Observational Studies. Al-Samkari H Otolaryngol Head Neck Surg; 2019 Feb; 160(2):368. PubMed ID: 30798765 [No Abstract] [Full Text] [Related]
25. Hereditary haemorrhagic telangiectasia: to transplant or not to transplant - is there a right time for liver transplantation? Muller YD; Oppliger R; Breguet R; Meyer P; Rubbia-Brandt L; Petignat PA; Harr T; Dayer E; Seebach JD Liver Int; 2016 Dec; 36(12):1735-1740. PubMed ID: 27864873 [TBL] [Abstract][Full Text] [Related]
26. Bevacizumab: an option for refractory epistaxis in hereditary haemorrhagic telangiectasia. Amann A; Steiner N; Gunsilius E Wien Klin Wochenschr; 2015 Aug; 127(15-16):631-4. PubMed ID: 25986996 [TBL] [Abstract][Full Text] [Related]
27. Response to "Systemic Bevacizumab for Hereditary Hemorrhagic Telangiectasia: Considerations from Observational Studies". Hsu YP; Hsu CW; Chen C Otolaryngol Head Neck Surg; 2019 Feb; 160(2):369-370. PubMed ID: 30798740 [No Abstract] [Full Text] [Related]
28. The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia. Simonds J; Miller F; Mandel J; Davidson TM Laryngoscope; 2009 May; 119(5):988-92. PubMed ID: 19194865 [TBL] [Abstract][Full Text] [Related]